Europe Neuropathic Pain Market
حجم السوق بالمليار دولار أمريكي
CAGR :
% 
 فترة التنبؤ |
2023 –2030 |
 حجم السوق (السنة الأساسية) |
USD 1,123.93 million |
 حجم السوق (سنة التنبؤ) |
USD 2,371.40 million |
 CAGR |
% |
| Major Markets Players |
سوق الألم العصبي في أوروبا، حسب النوع (أجهزة تحفيز النخاع الشوكي (SCS)، وتحفيز الأعصاب الطرفية الخارجية، وأجهزة تحفيز الأعصاب الكهربائية عبر الجلد (Tens))، ونوع المنتج (قابل لإعادة الشحن وغير قابل لإعادة الشحن)، والإجراء (جراحي وغير جراحي)، والتكنولوجيا (تحفيز الأعصاب الكهربائية عبر الجلد، والتحفيز المغناطيسي عبر الجمجمة والتحفيز الكهربائي التنفسي)، والوسيلة (ثابتة ومحمولة)، وطريقة الشراء (أجهزة بدون وصفة طبية وأجهزة تعتمد على الوصفة الطبية)، ونوع الألم (اعتلال الأعصاب الطرفية، واعتلال الأعصاب المحاصرة، واعتلال الأعصاب الوهمي للأطراف، وآلام العصب الثلاثي التوائم، وآلام الأعصاب التالية للهربس (PHN)، واعتلال الأعصاب التالي للصدمة، وآلام القدم، وألم العصعص)، والمؤشر (تضيق العمود الفقري، واعتلال الأعصاب الطرفية الناجم عن العلاج الكيميائي، واعتلال الأعصاب السكري، وغيرها)، المستخدم النهائي (المستشفيات والعيادات والرعاية الصحية المنزلية ومراكز الجراحة الخارجية وغيرها)، قناة التوزيع (العطاء المباشر والموزع التابع لطرف ثالث وغيرها) - اتجاهات الصناعة والتوقعات حتى عام 2030.
تحليل وحجم سوق الألم العصبي في أوروبا
من المتوقع أن يؤدي زيادة الإنفاق على البحث والتطوير من قبل مختلف اللاعبين في السوق لإنشاء منتجات متقدمة إلى دفع نمو سوق الألم العصبي في أوروبا. ومن المتوقع أن يعمل التقييد المرتبط بالأجهزة الطبية الذي يحد من استخدام المنتجات كقيد لنمو سوق الألم العصبي في أوروبا. إن ارتفاع خطر الإصابة بالألم العصبي مع الشيخوخة وارتفاع عدد السكان الأكبر سناً في العديد من البلدان سيخلق فرصة لنمو سوق الألم العصبي في أوروبا. ومن المتوقع أن يعمل استخدام العلاجات التقليدية في البلدان الناشئة بسبب انخفاض الإنفاق الصحي وسلسلة التوريد المعطلة كتحدي لنمو سوق الألم العصبي في أوروبا.
تحلل شركة Data Bridge Market Research أن سوق الألم العصبي في أوروبا، والذي بلغ 1,123.93 مليون دولار أمريكي في عام 2022، من المتوقع أن يصل إلى 2,371.40 مليون دولار أمريكي بحلول عام 2030، ومن المتوقع أن يخضع لمعدل نمو سنوي مركب بنسبة 9.1٪ خلال الفترة المتوقعة من 2023 إلى 2030. تهيمن شريحة "أجهزة تحفيز النخاع الشوكي (SCS)" على شريحة النوع في سوق الألم العصبي في أوروبا بسبب التقدم في التكنولوجيا. بالإضافة إلى الرؤى حول سيناريوهات السوق مثل القيمة السوقية ومعدل النمو والتجزئة والتغطية الجغرافية واللاعبين الرئيسيين، تتضمن تقارير السوق التي أعدتها شركة Data Bridge Market Research أيضًا تحليلًا عميقًا من الخبراء وعلم الأوبئة للمرضى وتحليل خطوط الأنابيب وتحليل الأسعار والإطار التنظيمي.
نطاق وتجزئة سوق الألم العصبي في أوروبا
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2023 إلى 2030 |
|
سنة الأساس |
2022 |
|
سنوات تاريخية |
2021 (قابلة للتخصيص حتى 2015-2020) |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية، الأحجام بالوحدات، التسعير بالدولار الأمريكي |
|
القطاعات المغطاة |
Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (Tens) Devices), Product Type (Rechargeable and Non-Rechargeable), Procedure (Invasive and Non-Invasive), Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation), Modality (Stationary and Portable), Mode of Purchase (Over-the-Counter Devices and Prescription-Based Devices), Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, Coccydynia), Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Others), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centres and Others), Distribution Channel (Direct Tender, Third Party Distributor and Others) |
|
Countries Covered |
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe |
|
Market Players Covered |
NEVRO CORP. (U.S.), Boston Scientific Corporation (U.S.), Abbott (U.S.), electroCore, Inc. (U.S.), Polar Medical (England) , B. Braun Melsungen AG (Germany), Omron Healthcare, Inc. (Japan), Cirtec (U.S.), Medtronic (Ireland), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Virpax Pharmaceuticals, Inc. (U.S.), Amgen Inc. (U.S.), Integer Holdings Corporation (U.S.) and AVNS (U.S.) |
|
Market Opportunities |
|
Market Definition
Neuropathic pain is caused by a lesion or disease of the somatosensory system including peripheral fibres (Aβ, Aδ and C fibres) and central neurons and affects 7–10% of the general population. Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the aging global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.
Europe Neuropathic Pain Market Dynamics
Drivers
- Increasing Prevalence of Neuropathic Pain
As the aging population grows and chronic diseases such as diabetes and cancer become more prevalent, the number of people suffering from neuropathic pain is on the rise. This demographic trend drives the demand for neuropathic pain treatments and medications.
- Advances in Medical Research
Ongoing research into the causes and mechanisms of neuropathic pain has led to the development of new treatment options and therapies. As our understanding of neuropathic pain improves, more effective treatments are being developed, creating opportunities for pharmaceutical and biotech companies.
- Novel Drug Development
Pharmaceutical companies are investing in the development of new drugs specifically designed to target neuropathic pain. These drugs aim to provide better pain relief with fewer side effects, improving the quality of life for patients.
Opportunities
- Growing Awareness among Patients
Increased awareness of neuropathic pain and its impact on patients’ lives has led to a greater demand for effective treatments. Patients are becoming more proactive in seeking appropriate care and therapies.
- Rising of Healthcare Expenditure
As healthcare expenditure continues to increase globally, there is more funding available for research, development, and access to neuropathic pain treatments and therapies.
Restraints/Challenges
- Limited Efficacy of Current Treatments
Many existing medications and therapies for neuropathic pain offer only partial relief and can have side effects. This limited efficacy can lead to patient dissatisfaction and the search for alternative treatments.
-
Side Effects and Safety Concerns
Some neuropathic pain medications, including opioids and certain antidepressants, can cause side effects such as drowsiness, dizziness, and addiction. Managing these side effects can be challenging for both patients and healthcare providers.
This Europe neuropathic pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe neuropathic pain market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In January 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes
- In July 2022, Vertex Pharmaceuticals Incorporated announced positive Phase 2 results of VX-548 in Acute and Neuropathic Pain by U.S. Food and Drug Administration (FDA)
Europe Neuropathic Pain Market Scope
The Europe neuropathic pain Market is segmented on the basis of type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Spinal Cord Stimulation (SCS) Devices
- External Peripheral Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation (Tens) Devices
Product Type
- Rechargeable
- Non-Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
Modality
- Stationary
- محمول
طريقة الشراء
- الأجهزة المتاحة دون وصفة طبية
- الأجهزة المعتمدة على الوصفات الطبية
نوع الألم
- اعتلال الأعصاب الطرفية
- اعتلال الأعصاب المحاصر
- اعتلال الأعصاب الوهمي
- ألم العصب الثلاثي التوائم
- الألم العصبي التالي للهربس (PHN)
- اعتلال الأعصاب ما بعد الصدمة
- ألم القدم
- ألم العصعص
إشارة
- تضيق العمود الفقري
- اعتلال الأعصاب الطرفية الناجم عن العلاج الكيميائي
- اعتلال الأعصاب السكري
- آحرون
المستخدم النهائي
- المستشفيات
- العيادات
- الرعاية الصحية المنزلية
- مراكز الجراحة الخارجية
- آحرون
قناة التوزيع
- العطاء المباشر
- موزع الطرف الثالث
- آحرون
تحليل/رؤى إقليمية لسوق الألم العصبي في أوروبا
يتم تحليل سوق الألم العصبي في أوروبا ويتم توفير رؤى حجم السوق والاتجاهات حسب البلد والنوع ونوع المنتج والإجراء والتكنولوجيا والوسيلة وطريقة الشراء ونوع الألم والمؤشر والمستخدم النهائي وقناة التوزيع كما هو مذكور أعلاه.
الدول التي يغطيها تقرير سوق الألم العصبي في أوروبا هي ألمانيا وفرنسا والمملكة المتحدة وهولندا وسويسرا وبلجيكا وروسيا وإيطاليا وإسبانيا وتركيا وبقية أوروبا
تهيمن ألمانيا على سوق الألم العصبي في أوروبا بسبب القاعدة القوية للمرافق الصحية، والحضور القوي للاعبين الرئيسيين في السوق، والعدد المتزايد من أنشطة البحث في هذه المنطقة.
من المتوقع أن تشهد ألمانيا نموًا كبيرًا في سوق الألم العصبي في أوروبا خلال الفترة المتوقعة من 2023 إلى 2030 بسبب الزيادة في المبادرات الحكومية لتعزيز الوعي، وارتفاع السياحة الطبية، وأنشطة البحث المتزايدة في المنطقة، وتوافر أسواق ضخمة غير مستغلة، وتجمع سكاني كبير، والطلب المتزايد على الرعاية الصحية عالية الجودة في المنطقة.
يقدم قسم الدولة في التقرير أيضًا عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب، والاتجاهات الفنية وتحليل قوى بورتر الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. أيضًا، يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية وطرق التجارة أثناء تقديم تحليل توقعات لبيانات الدولة.
نمو البنية التحتية للرعاية الصحية والقاعدة المثبتة واختراق التكنولوجيا الجديدة
كما يوفر لك سوق الألم العصبي في أوروبا تحليلاً تفصيلياً للسوق لكل دولة من حيث نمو الإنفاق على الرعاية الصحية للمعدات الرأسمالية، والقاعدة المثبتة من أنواع مختلفة من المنتجات لسوق الألم العصبي في أوروبا، وتأثير التكنولوجيا باستخدام منحنيات خط الحياة والتغييرات في سيناريوهات التنظيم الصحي وتأثيرها على سوق الألم العصبي في أوروبا. البيانات متاحة للفترة التاريخية 2015-2020.
تحليل المشهد التنافسي وحصة سوق علاج الألم العصبي في أوروبا
يقدم المشهد التنافسي لسوق الألم العصبي في أوروبا تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بسوق الألم العصبي في أوروبا.
بعض اللاعبين الرئيسيين العاملين في سوق الألم العصبي في أوروبا هم:
- شركة نيفرو (الولايات المتحدة)
- شركة بوسطن العلمية (الولايات المتحدة)
- أبوت (الولايات المتحدة)
- شركة electroCore، (الولايات المتحدة)
- بولار ميديكال (انجلترا)
- B. Braun Melsungen AG (ألمانيا)
- شركة أومرون للرعاية الصحية (اليابان)
- سيرتيك (الولايات المتحدة)
- ميدترونيك (ايرلندا)
- شركة فايزر (الولايات المتحدة)
- نوفارتيس أيه جي (سويسرا)
- شركة فيرباكس للأدوية (الولايات المتحدة)
- شركة أمجين (الولايات المتحدة)
- شركة إنتيجر القابضة (الولايات المتحدة)
- AVNS (الولايات المتحدة)
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE Neuropathic pain MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET type of manufacturer COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- regulation
- REGULATORY GUIDELINES AS PER USFDA
- REGULATORY GUIDELINES AS PER EUROPEAN UNION
- market overview
- drivers
- Growing prevalence of chronic pain and neuropathic condition
- Increasing Cases Of Diabetic Neuropathy
- Increasing R&D Expenditure
- Advancement In New Neuromodulation Technology
- Penetration Of the New Market Players
- RESTRAINTS
- High cost of the medical devices
- Low awareness for neuropathic pain devices
- unfavorable government policies
- Limitation of Neuropathic medical Devices
- OPPORTUNITIES
- High Risk Of Neuropathic Pain With Ageing
- Government initiatives for neuropathic pain
- Appropriate Reimbursement policy for the medical devices
- CHALLENGES
- Dearth of skilled professionals
- Use of traditional therapy in emerging economies
- IMPACT OF COVID-19 ON THE EUROPE NEUROPATHIC PAIN MARKET
- OVERVIEW
- IMPACT ON PRICE
- IMPACT ON SUPPLY
- STRATEGIC DECISIONS BY MANUFACTURERS
- CONCLUSION-
- europe Neuropathic pain MARKET, BY Type
- overview
- SPINAL CORD STIMULATION (SCS) DEVICES
- Rechargeable Implantable Pulse Generator
- Radiofrequency Stimulator
- Conventional Implantable Pulse Generator/ IPG
- EXTERNAL PERIPHERAL NERVE STIMULATION
- Deep Brain Stimulators (DBS)
- Dual-Channel Deep Brain Stimulator
- Single-Channel Deep Brain Stimulator
- Transcranial Magnetic Stimulators (TMS)
- Vagus Nerve Stimulators (VNS)
- Sacral Nerve Stimulators (SNS)
- TRANSCUTANEOUS ELECTRIC NERVE STIMULATION (TENS) DEVICES
- Conventional Tens (Low-intensity, High-Frequency)
- Acupuncture-Like Tens (High-Intensity, Low-Frequency)
- Intense Tens (High-Intensity, High-Frequency)
- europe Neuropathic pain MARKET, BY product type
- overview
- rechargeable
- non- rechargeable
- europe Neuropathic pain MARKET, BY Procedure
- overview
- Non-Invasive
- invasive
- europe Neuropathic pain MARKET, BY technology
- overview
- TRANSCUTANEOUS ELECTRIC NERVE STIMULATION
- TRANSCRANIAL MAGNETIC STIMULATION
- Respiratory Electrical Stimulation
- europe Neuropathic pain MARKET, BY Modality
- overview
- portable
- Rechargeable
- Non- Rechargeable
- stationary
- Rechargeable
- Non- Rechargeable
- europe Neuropathic pain MARKET, BY Mode of Purchase
- overview
- Prescription-Based Devices
- Over-The-Counter Devices
- europe Neuropathic pain MARKET, BY Pain Type
- overview
- Peripheral Neuropathy
- Phantom Limb Pain
- Post Herpetic Neuralgia (PHN)
- Post Traumatic Neuropathy
- Entrapment Neuropathy
- Foot Pain
- Trigeminal Neuralgia
- Coccydynia
- others
- europe Neuropathic pain MARKET, BY indication
- overview
- Spinal Stenosis
- Spinal Cord Stimulation (SCS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) devices
- External Peripheral Nerve Stimulation
- Diabetic Neuropathy
- Spinal Cord Stimulation (SCS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) devices
- External Peripheral Nerve Stimulation
- Chemotherapy-Induced Peripheral Neuropathy
- Spinal Cord Stimulation (SCS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) devices
- External Peripheral Nerve Stimulation
- others
- europe Neuropathic pain MARKET, BY end user
- overview
- Clinics
- Hospitals
- Acute Care Hospitals
- Long-Term Care Hospitals
- Nursing Facilities
- Rehabilitation Centers
- Home Healthcare
- Ambulatory Surgical Centers
- others
- europe Neuropathic pain MARKET, BY distribution channel
- overview
- Direct Tenders
- Third Party Distribution
- others
- Europe neuropathic Pain market by geography
- Overview
- EUROPE
- GERMANY
- france
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Turkey
- Switzerland
- Rest of Europe
- Europe Neuropathic Pain Market: COMPANY landscape
- company share analysis: europe
- swot analysis
- Company profile
- medtronic
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- boston scientific corporation
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ABBOTT
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- nervo corp.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- omron healthcare, INC.
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Interger holdings corporation
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- avns
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- b.braun melsungen AG
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Cirtec
- 257
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ELECTROCORE, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Neurometrix, inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Polar medical
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Spr therapeutics
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Stimwave LLC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- sunmed
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
List of Table
TABLE 1 Europe Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 2 Europe Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 3 Europe Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 4 Europe External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 5 Europe External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 6 Europe Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 7 Europe Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 8 Europe Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)
TABLE 9 Europe Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 10 Europe Rechargeable in Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 11 Europe Non-Rechargeable Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)
TABLE 12 Europe Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 13 Europe Non-Invasive Invasive in Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)
TABLE 14 Europe Invasive in Neuroendocrine Tumors Market, By Classification 2019-2027 (USD Million)
TABLE 15 Europe Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 16 Europe Transcutaneous Electrical Nerve Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 17 Europe Transcranial Magnetic Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 18 Europe Respiratory Electrical Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)
TABLE 19 Europe Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 20 Europe Portable Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 21 Europe Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 22 Europe Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 23 Europe Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)
TABLE 24 Europe Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 25 Europe Prescription-Based Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 26 Europe Over-The-Counter Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)
TABLE 27 Europe Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 28 Europe Peripheral Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 29 Europe Phantom Limb Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 30 Europe Post Herpetic Neuralgia (PHN) Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 31 Europe Post Traumatic NeuropathyNeuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 32 Europe Entrapment Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 33 Europe Foot Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 34 Europe Trigeminal Neuralgia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 35 Europe Coccydynia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 36 Europe Others Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)
TABLE 37 Europe Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 38 Europe Spinal Stenosis Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 39 Europe Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 40 Europe Diabetic Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 41 Europe Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 42 Europe Chemotherapy-Induced Peripheral Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 43 Europe Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 44 Europe Others Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)
TABLE 45 Europe Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 46 Europe Clinics Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 47 Europe Hospitals Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 48 Europe Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 49 Europe Home Healthcare Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 50 Europe Ambulatory Surgical Centers Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 51 Europe Others Neuropathic Pain Market, By End User, 2019-2028 (USD Million)
TABLE 52 Europe Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 53 Europe Direct Tenders Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 54 Europe Third Party Distribution Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 55 Europe Others Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 56 EUROPE neuropathic Pain MARKET, BY REGION , 2021-2028 (USD MILLION)
TABLE 57 Europe NEUROPATHIC PAIN MARKET, By Region, 2019-2028 (USD Million)
TABLE 58 EUROPE NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 59 EUROPE Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 60 EUROPE External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 61 EUROPE Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 62 EUROPE Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 63 EUROPE NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 64 EUROPE NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 65 EUROPE NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 66 EUROPE NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 67 EUROPE Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 68 EUROPE portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 69 EUROPE NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 70 EUROPE NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 71 EUROPE NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 72 EUROPE SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 73 EUROPE Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 74 EUROPE Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 75 EUROPE NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 76 EUROPE hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 77 EUROPE NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 78 GERMANY NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 79 GERMANY Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 80 GERMANY External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 81 germany Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 82 GERMANY Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 83 GERMANY NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 84 GERMANY NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 85 GERMANY NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 86 GERMANY NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 87 GERMANY Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 88 GERMANY portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 89 GERMANY NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 90 GERMANY NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 91 GERMANY NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 92 GERMANY SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 93 GERMANY Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 94 GERMANY Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 95 GERMANY NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 96 GERMANY hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 97 GERMANY NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 98 france NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 99 france Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 100 france External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 101 france Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 102 france Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 103 france NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 104 france NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 105 france NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 106 france NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 107 france Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 108 france portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 109 france NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 110 france NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 111 france NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 112 france SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 113 france Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 114 france Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 115 france NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 116 france hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 117 france NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 118 U.K. NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 119 U.K. Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 120 U.K. External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 121 U.K. Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 122 U.K. Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 123 U.K. NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 124 U.K. NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 125 U.K. NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 126 U.K. NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 127 U.K. Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 128 U.K. portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 129 U.K. NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 130 U.K. NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 131 U.K. NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 132 U.K. SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 133 U.K. Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 134 U.K. Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 135 U.K. NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 136 U.K. hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 137 U.K. NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 138 italy NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 139 italy Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 140 italy External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 141 italy Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 142 italy Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 143 italy NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 144 italy NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 145 italy NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 146 italy NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 147 italy Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 148 italy portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 149 italy NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 150 italy NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 151 italy NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 152 italy SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 153 italy Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 154 italy Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 155 italy NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 156 italy hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 157 italy NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 158 russia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 159 russia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 160 russia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 161 russia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 162 russia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 163 russia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 164 russia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 165 russia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 166 russia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 167 russia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 168 russia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 169 russia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 170 russia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 171 russia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 172 russia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 173 russia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 174 russia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 175 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 176 russia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 177 russia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 178 spain NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 179 spain Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 180 spain External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 181 spain Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 182 spain Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 183 spain NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 184 spain NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 185 spain NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 186 spain NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 187 spain Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 188 spain portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 189 spain NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 190 spain NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 191 spain NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 192 spain SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 193 spain Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 194 spain Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 195 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 196 spain hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 197 spain NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 198 Netherlands NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 199 Netherlands Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 200 Netherlands External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 201 Netherlands Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 202 Netherlands Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 203 Netherlands NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 204 Netherlands NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 205 Netherlands NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 206 Netherlands NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 207 Netherlands Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 208 Netherlands portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 209 Netherlands NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 210 Netherlands NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 211 Netherlands NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 212 Netherlands SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 213 Netherlands Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 214 Netherlands Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 215 Netherlands NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 216 Netherlands hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 217 Netherlands NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 218 turkey NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 219 turkey Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 220 turkey External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 221 turkey Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 222 turkey Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 223 turkey NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 224 turkey NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 225 turkey NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 226 turkey NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 227 turkey Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 228 turkey portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 229 turkey NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 230 turkey NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 231 turkey NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 232 turkey SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 233 turkey Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 234 turkey Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 235 turkey NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 236 turkey hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 237 turkey NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 238 Switzerland NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 239 Switzerland Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 240 Switzerland External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 241 Switzerland Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 242 Switzerland Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
TABLE 243 Switzerland NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)
TABLE 244 Switzerland NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)
TABLE 245 Switzerland NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)
TABLE 246 Switzerland NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 247 Switzerland Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 248 Switzerland portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)
TABLE 249 Switzerland NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)
TABLE 250 Switzerland NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)
TABLE 251 Switzerland NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 252 Switzerland SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 253 Switzerland Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 254 Switzerland Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)
TABLE 255 Switzerland NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 256 Switzerland hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)
TABLE 257 Switzerland NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 258 Rest of Europe NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)
List of Figure
FIGURE 1 Europe NEUROPATHIC PAIN MARKET: SEGMENTATION
FIGURE 2 EUROPE NEUROPATHIC PAIN MARKET: DATA TRIANGULATION
FIGURE 3 europe Neuropathic pain Market: DROC ANALYSIS
FIGURE 4 Europe Neuropathic pain market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Neuropathic pain Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Neuropathic pain MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Neuropathic pain MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE NEUROPATHIC PAIN MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE NEUROPATHIC PAIN MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE Neuropathic pain MARKET: MARKET type COVERAGE GRID
FIGURE 11 Europe Neuropathic pain market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE THE EUROPE Neuropathic pain market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC PAIN, NEUROPATHIC CONDITION, AND INCREASING CASES OF DIABETIC NEUROPATHY IS DRIVING THE EUROPE NEUROPATHIC PAIN MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 SPINAL CORD STIMULATION (SCS) DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE NEUROPATHIC PAIN MARKET IN 2021 & 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE NEUROPATHIC PAIN MARKET
FIGURE 16 ESTIMATED CASES OF PERIPHERAL NEUROPATHY IN AMERICAN POPULATION
FIGURE 17 PREVALENCE OF NEUROPATHIC PAIN IN TYPE 1 AND TYPE 2 DIABETES
FIGURE 18 europe Neuropathic pain market: BY type, 2020
FIGURE 19 europe Neuropathic pain market: BY type, 2020-2028 (USD Million)
FIGURE 20 europe Neuropathic pain market: BY type, CAGR (2020-2028)
FIGURE 21 europe Neuropathic pain market: BY type, LIFELINE CURVE
FIGURE 22 europe Neuropathic pain market: BY product type, 2020
FIGURE 23 europe Neuropathic pain market: BY product type, 2020-2028 (USD Million)
FIGURE 24 europe Neuropathic pain market: BY product type, CAGR (2020-2028)
FIGURE 25 europe Neuropathic pain market: BY product type, LIFELINE CURVE
FIGURE 26 europe Neuropathic pain market: BY procedure, 2020
FIGURE 27 europe Neuropathic pain market: BY procedure, 2020-2028 (USD Million)
FIGURE 28 europe Neuropathic pain market: BY procedure, CAGR (2020-2028)
FIGURE 29 europe Neuropathic pain market: BY procedure, LIFELINE CURVE
FIGURE 30 europe Neuropathic pain market: BY technology, 2020
FIGURE 31 europe Neuropathic pain market: BY technology, 2020-2028 (USD Million)
FIGURE 32 europe Neuropathic pain market: BY technology, CAGR (2020-2028)
FIGURE 33 europe Neuropathic pain market: BY technology, LIFELINE CURVE
FIGURE 34 europe Neuropathic pain market: BY modality, 2020
FIGURE 35 europe Neuropathic pain market: BY modality, 2020-2028 (USD Million)
FIGURE 36 europe Neuropathic pain market: BY modality, CAGR (2020-2028)
FIGURE 37 europe Neuropathic pain market: BY modality, LIFELINE CURVE
FIGURE 38 europe Neuropathic pain market: BY mode of purchase, 2020
FIGURE 39 europe Neuropathic pain market: BY mode of purchase, 2020-2028 (USD Million)
FIGURE 40 europe Neuropathic pain market: BY mode of purchase, CAGR (2020-2028)
FIGURE 41 europe Neuropathic pain market: BY mode of purchase, LIFELINE CURVE
FIGURE 42 europe Neuropathic pain market: BY pain type, 2020
FIGURE 43 europe Neuropathic pain market: BY pain type, 2020-2028 (USD Million)
FIGURE 44 europe Neuropathic pain market: BY pain type, CAGR (2020-2028)
FIGURE 45 europe Neuropathic pain market: BY pain type, LIFELINE CURVE
FIGURE 46 europe Neuropathic pain market: BY indication, 2020
FIGURE 47 europe Neuropathic pain market: BY indication, 2020-2028 (USD Million)
FIGURE 48 europe Neuropathic pain market: BY indication, CAGR (2020-2028)
FIGURE 49 europe Neuropathic pain market: BY indication, LIFELINE CURVE
FIGURE 50 europe Neuropathic pain market: BY end user, 2020
FIGURE 51 europe Neuropathic pain market: BY end user, 2020-2028 (USD Million)
FIGURE 52 europe Neuropathic pain market: BY end user, CAGR (2020-2028)
FIGURE 53 europe Neuropathic pain market: BY end user, LIFELINE CURVE
FIGURE 54 europe Neuropathic pain market: BY distribution channel, 2020
FIGURE 55 europe Neuropathic pain market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 56 europe Neuropathic pain market: BY distribution channel, CAGR (2020-2028)
FIGURE 57 europe Neuropathic pain market: BY distribution channel, LIFELINE CURVE
FIGURE 58 EUROPE neuropathic Pain market: SNAPSHOT (2020)
FIGURE 59 EUROPE neuropathic Pain market: BY COUNTRY (2020)
FIGURE 60 EUROPE neuropathic Pain market: BY COUNTRY (2021 & 2028)
FIGURE 61 EUROPE neuropathic Pain market: BY COUNTRY (2020 & 2028)
FIGURE 62 EUROPE neuropathic Pain market: BY Product & services (2021-2028)
FIGURE 63 Europe Neuropathic Pain MARKET: SNAPSHOT (2020)
FIGURE 64 Europe Neuropathic Pain MARKET: BY COUNTRY (2020)
FIGURE 65 Europe Neuropathic Pain MARKET: BY COUNTRY (2021 & 2028)
FIGURE 66 Europe Neuropathic Pain MARKET: BY COUNTRY (2020 & 2028)
FIGURE 67 Europe Neuropathic Pain MARKET: BY product & Services (2021-2028)
FIGURE 68 Europe Neuropathic Pain market: company share 2020 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
